Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

French stocks rose slightly on Wednesday ahead of a crucial no-confidence vote by lawmakers in parliament against Prime Minister ...

Health-care companies ticked down, but remained near all-time highs, amid promising drug developments in the biotech niche. Janux Therapeutics stock surged after the California biotech concern's ...

A change in FTC leadership would likely see a relaxation of antitrust enforcement and an increase in biopharma M&A activity.

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a pharmaceutical company focused on the development and commercialization of innovative therapies, today announced it has entered into ...

With the incoming Trump administration and a Republican-controlled Congress, significant policy shifts are expected for the ...

AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while ...